FLAVIO TARASOUTCHI

(Fonte: Lattes)
Índice h a partir de 2011
14
Lattes
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação, Hospital das Clínicas, Faculdade de Medicina
LIM/64, Hospital das Clínicas, Faculdade de Medicina - Líder

Filtros

Limpar filtros

Configurações

search.filters.applied.f.dateIssued: 2022 ×

Resultados de Busca

Agora exibindo 1 - 9 de 9
  • conferenceObject
    Long-term prognostic impact of pulmonary vascular resistance in patients with rheumatic mitral stenosis undergoing percutaneous mitral balloon valvuloplasty
    (2022) NAZZETTA, D. Cian; SOUSA, L. C. G. De; ROSA, V. E. E.; TESSARI, F. C.; PESSOA, R. S.; LIPARI, L. F. V. P.; FERNANDES, J. R. C.; LOPES, M. P.; SANTIS, A. S. A. L. De; SPINA, G. S.; PIRES, L. J. N. T.; SAMPAIO, R. O.; TARASOUTCHI, F.
  • conferenceObject
    COMMANDO SURGERY AS THE THIRD REOPERATION OF A RHEUMATIC PATIENT WITH SEVERE MITRAL-AORTIC-PROSTHESIS DYSFUNCTION AND MISMATCH: A CASE REPORT
    (2022) MAZETTO, Amanda Bergamo; GONCALVES, Rallyson De Oliveira; STEIN, Julien Ramos; ACCORSI, Tarso Augusto; STEFFEN, Samuel Padovani; TARASOUTCHI, Flavio; ROCHA, Aroni Marceu Sousa e; ANDRADE, Ana Flavia Diez de; CAMPOS, Joaquim Tenente Ana de; GAIOTTO, Fabio Antonio
  • article 9 Citação(ões) na Scopus
    Comprehensive myocardial characterization using cardiac magnetic resonance associates with outcomes in low gradient severe aortic stenosis
    (2022) FUKUI, Miho; ANNABI, Mohamed-Salah; ROSA, Vitor E. E.; RIBEIRO, Henrique B.; I, Larissa Stanberry; CLAVEL, Marie-Annick; RODES-CABAU, Josep; TARASOUTCHI, Flavio; SCHELBERT, Erik B.; BERGLER-KLEIN, Jutta; BARTKO, Philipp E.; DONA, Carolina; MASCHERBAUER, Julia; DAHOU, Abdellaziz; ROCHITTE, Carlos E.; PIBAROT, Philippe; CAVALCANTE, Joao L.
    Aims This study sought to compare cardiac magnetic resonance (CMR) characteristics according to different flow/gradient patterns of aortic stenosis (AS) and to evaluate their prognostic value in patients with low-gradient AS. Methods and results This international prospective multicentric study included 147 patients with low-gradient moderate to severe AS who underwent comprehensive CMR evaluation of left ventricular global longitudinal strain (LVGLS), extracellular volume fraction (ECV), and late gadolinium enhancement (LGE). All patients were classified as followings: classical low-flow low-gradient (LFLG) [mean gradient (MG) < 40 mmHg and left ventricular ejection fraction (LVEF) < 50%]; paradoxical LFLG [MG < 40 mmHg, LVEF >= 50%, and stroke volume index (SVi) < 35 ml/m(2)]; and normal-flow low-gradient (MG < 40 mmHg, LVEF >= 50%, and SVi >= 35 ml/m(2)). Patients with classical LFLG (n = 90) had more LV adverse remodelling including higher ECV, and higher LGE and volume, and worst LVGLS. Over a median follow-up of 2 years, 43 deaths and 48 composite outcomes of death or heart failure hospitalizations occurred. Risks of adverse events increased per tertile of LVGLS: hazard ratio (HR) = 1.50 [95% CI, 1.02-2.20]; P = 0.04 for mortality; HR = 1.45 [1.01-2.09]; P < 0.05 for composite outcome; per tertile of ECV, HR = 1.63 [1.07-2.49]; P = 0.02 for mortality; HR = 1.54 [1.02-2.33]; P = 0.04 for composite outcome. LGE presence also associated with higher mortality, HR = 2.27 [1.01-5.11]; P < 0.05 and composite outcome, HR = 3.00 [1.16-7.73]; P = 0.02. The risk of mortality and the composite outcome increased in proportion to the number of impaired components (i.e. LVGLS, ECV, and LGE) with multivariate adjustment. Conclusions In this international prospective multicentric study of low-gradient AS, comprehensive CMR assessment provides independent prognostic value that is cumulative and incremental to clinical and echocardiographic characteristics.
  • article 0 Citação(ões) na Scopus
  • conferenceObject
    LEFT VENTRICULAR PSEUDOANEURYSM AS A COMPLICATION OF MITRAL VALVE REPLACEMENT SURGERY
    (2022) SOARES, Fernanda; ALMEIDA, Camila; ACCORSI, Tarso Augusto; TARASOUTCHI, Flavio; LIPARI, Layara Fernanda; PEREIRA, Thiago; TESSARI, Fernanda; SIQUEIRA, Bernardo; OLIVEIRA, Renan; CUNHA, Matheus Luan
  • conferenceObject
    Transcatheter aortic valve implantation without contrast media technique in chronic kidney disease population - pilot study
    (2022) NICZ, P.; FREIRE, A. F. D.; FILIPPINI, F. B.; KANHOUCHE, G.; ACCORSI, T. A. D.; RIBEIRO, H. B.; LIBERATO, G.; NOMURA, C. H.; CASSAR, R. S.; VIEIRA, M. L.; MATHIAS, W.; POMERANTZEFF, P. M. A.; TARASOUTCHI, F.; ABIZAID, A.; BRITO JR., F. S. De
  • article 1 Citação(ões) na Scopus
    Clinical Profile and 30-Day Outcomes of Patients with Bicuspid Aortic Valve Undergoing Aortic Valve and/or Aorta Surgery
    (2022) KIRSCHBAUM, Marcelo; ROSA, Vitor Emer Egypto; SAMPAIO, Brunna Pileggi Azevedo; THEVENARD, Gabriela; QUINTANILHA, Nadia Romanelli; FERNANDES, Joao Ricardo Cordeiro; SANTIS, Antonio de; ACCORSI, Tarso Duenhas; SAMPAIO, Roney Orismar; TARASOUTCHI, Flavio
    Background: The bicuspid aortic valve (BAV) affects 0.5 to 2% of the population and is associated with valve and aortic alterations. There is a lack of studies on the profile of these patients in the Brazilian population. Objective: To describe the profile of patients with BAV undergoing valve and/or aortic surgery in a tertiary cardiology center, in addition to the outcomes related to the intervention. Methods: Retrospective cohort including 195 patients (mean age 54 +/- 14 years, 73.8% male) diagnosed with BAV who underwent surgical approach (valvular and/or aorta) from 2014 to 2019. Clinical data, echocardiographic and tomographic studies were evaluated, as well as characteristics of the intervention and events in 30 days. A value of p<0.05 was considered statistically significant. Results: We found a high prevalence of aortic aneurysm (56.5%), with a mean diameter of 46.9 +/- 10.2 mm. Major aortic regurgitation was found in 25.1% and major aortic stenosis in 54.9%. Isolated aortic valve surgery was performed in 48.2%, isolated aortic surgery in 6.7% and combined surgery in 45.1%. The 30-day mortality was 8.2%. In the multivariate analysis, the predictors of the combined outcome at 30 days (death, atrial fibrillation and reoperation) were age (OR 1.044, 95% CI 1.009-1.081, p =0.014) and left ventricular mass index (OR 1.009, 95% CI 1.000-1.018, p =0.044). Conclusion: Patients with BAV approached in our service have a higher incidence of aortopathy, with the additional need to evaluate the aorta with computed tomography or magnetic resonance imaging.
  • article 0 Citação(ões) na Scopus
    Delayed left main coronary obstruction following transfemoral inovare transcatheter aortic valve replacement: A challenging case
    (2022) KANHOUCHE, G.; CIVIDANES, F. R.; SAMPAIO, R. O.; SILVA, J. C. A. da; MACHADO, R. D.; WERNECK, M.; ACCORSI, T. A. D.; MORALES, K. R. D. P.; ABIZAID, A. C.; BRITO, F. S. D. Jr.; TARASOUTCHI, F.; PALMA, J. H.; RIBEIRO, H. B.
    Coronary obstruction is an uncommon and severe complication after a transcatheter aortic valve replacement (TAVR), that occurs during the procedure in the vast majority of patients. In the present case even in the absence of classic risk factors, an acute coronary syndrome occurred one day after TAVR. Selective angiography revealed a severe left main ostium obstruction by the bulky native leaflet calcification. This is the first case of delayed presentation of coronary obstruction with a transfemoral balloon-expandable valve using the Inovare bioprosthesis (Braile Biomedica, Brazil). In addition, after drug-eluting stent placement in the left main coronary, intravascular ultrasound revealed severe stent underexpansion, so that a second layer of a bare-metal stent and high-pressure balloon post-dilatation was necessary to improve the final result. The patient was discharged after 7 days, and at the 6-month follow-up remained asymptomatic.
  • article 2 Citação(ões) na Scopus
    Splenic Abscesses in Endocarditis: A Rare Disease with High Mortality. The Experience of a Heart Institute in Brazil
    (2022) RASSLAN, Roberto; ALVES, Vinicios; DAMOUS, Sergio Henrique Bastos; SANTIS, Antonio de; TARASOUTCHI, Flavio; MENEGOZZO, Calos Augusto Metidieri; AKAMINE, Masahiko; RASSLAN, Samir; UTIYAMA, Edivaldo Massazo
    Introduction Splenic abscess secondary to endocarditis is a rare complication with high mortality. The treatment modality, splenectomy versus percutaneous drainage, and the best time, before or after valve replacement, are controversial. In the literature, there are only a few small case series about the subject. The objective of this study is to analyze the experience of a referral center in treating such condition. Methods Patients with splenic abscesses due to endocarditis from 2006 to 2020 were retrospectively analyzed. Results Thirteen patients (mean age 46 years old, 69% male) were identified. Eight patients (62%) had at least 2 comorbidities and 5 (38%) had a history of cardiac surgery. The diagnosis was incidental in 6 (46%). The mean time of abscess diagnosis after endocarditis definition was 14 days. Six patients (46%) had at least two organ dysfunctions. The median APACHE II score was 12 overall, and 24.5 in patients who died. Six patients (46%) had a valve replacement, and in two the abscess was diagnosed postoperatively. Of the other four patients, splenectomy was performed before the cardiac operation in three and at the same time in one. Splenectomy was performed immediately in 9 (69%) patients while three patients had percutaneous drainage (23%), one of which underwent splenectomy due to drainage failure. Exclusive antibiotic treatment was performed on only one patient. The median length of hospitalization was 24 days and mortality was 46%. Conclusion Splenic abscess due to endocarditis is a life-threatening condition with controversial treatment that results in a prolonged length of stay and high mortality.